Interchange Capital Partners LLC lessened its stake in Danaher Co. (NYSE:DHR – Free Report) by 12.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,787 shares of the conglomerate’s stock after selling 244 shares during the quarter. Interchange Capital Partners LLC’s holdings in Danaher were worth $412,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of DHR. ICW Investment Advisors LLC lifted its stake in Danaher by 4.8% during the fourth quarter. ICW Investment Advisors LLC now owns 4,982 shares of the conglomerate’s stock worth $1,144,000 after purchasing an additional 228 shares during the last quarter. Congress Wealth Management LLC DE lifted its position in shares of Danaher by 6.1% in the 4th quarter. Congress Wealth Management LLC DE now owns 12,749 shares of the conglomerate’s stock worth $2,927,000 after buying an additional 736 shares during the last quarter. Crowley Wealth Management Inc. acquired a new position in shares of Danaher in the 4th quarter valued at about $69,000. Vanguard Group Inc. grew its position in shares of Danaher by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate’s stock valued at $13,715,641,000 after buying an additional 315,912 shares during the last quarter. Finally, LPL Financial LLC raised its stake in Danaher by 6.0% during the fourth quarter. LPL Financial LLC now owns 402,244 shares of the conglomerate’s stock worth $92,335,000 after acquiring an additional 22,903 shares during the period. Institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
Several research firms have recently commented on DHR. Barclays lowered their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Guggenheim started coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a report on Friday, March 14th. The Goldman Sachs Group raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 price objective on the stock in a report on Friday. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Five investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $278.24.
Danaher Stock Performance
NYSE:DHR opened at $212.97 on Tuesday. The company has a 50-day moving average of $216.92 and a 200-day moving average of $238.13. The firm has a market cap of $152.21 billion, a price-to-earnings ratio of 40.33, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. Analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s payout ratio is presently 24.24%.
Insider Transactions at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.